Denali Therapeutics (NasdaqGS:DNLI) Update / briefing March 25, 2026 12:30 PM ET Company ParticipantsAlexander Schuth - CFO and COOAndrew Tsai - Managing DirectorJohn Kreger - Director of ResearchKatie Peng - Chief Commercial OfficerLaura Chico - Managing Director of Equity ResearchLaura Hansen - VP of Investor RelationsLydia Erdman - Biotech Equity Research AssociateMayank Mamtani - Senior Managing Director and Group Head of HealthcareMike Riad - VPPeter Chin - Chief Medical OfficerPeyton Bohnsack - VP of ...